Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

PHOTO GALLERY from AMA House of Delegates 2022 meeting

Here are images from the American Medical Association (AMA) 2022 House of Delegates (HOD) meeting in Chicago, June 10-15. This was the first time the HOD met in two and a half years because of the COVID-19 pandemic.

Thumbnail

How one billionaire is fighting hospital monopolies

John Arnold, a Texas billionaire, has a gear to grind with big hospital monopolies.

HHS launches $1M competition for primary care innovation

The Department of Health and Human Services (HHS) announced a competition to find new innovations in patient access to primary care––with a total of $1 million in prizes attached.

Thumbnail

Bipartisan gun violence proposal earns applause from medical groups

The proposal comes after several healthcare CEOs signed onto a letter demanding action from Congress on gun violence.

Thumbnail

AMA maps out 5-point ‘road to recovery’ for frazzled physicians

Supporting telehealth, reforming Medicare, fixing the prior authorization process—these are three of five goals the American Medical Association is pursuing in an expansive new program.

Healthcare CEOs urge Congress to act on gun violence

Among the CEOs who signed the letter are a handful of prominent healthcare leaders.

Novavax NVX-CoV2373 COVID-19 vaccine myocarditis

FDA committee backs Novavax's COVID-19 vaccine despite heart damage concerns

The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.  

mergers acquisitions puzzle M&A

HCA’s latest deals on pause by FTC

The news comes just after HCA Healthcare was hit with a second antitrust lawsuit for anticompetitive actions.

Displaying 657 - 664 of 3407

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.